Duality Advisers’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-77,298
| Closed | -$913K | – | 615 |
|
|
2022
Q4 | $913K | Buy |
77,298
+20,494
| +36% | +$242K | 0.1% | 333 |
|
|
2022
Q3 | $1.19M | Sell |
56,804
-8,846
| -13% | -$186K | 0.13% | 274 |
|
|
2022
Q2 | $2.04M | Buy |
65,650
+59,009
| +889% | +$1.83M | 0.2% | 191 |
|
|
2022
Q1 | $273K | Sell |
6,641
-13,778
| -67% | -$566K | 0.03% | 565 |
|
|
2021
Q4 | $888K | Sell |
20,419
-43,506
| -68% | -$1.89M | 0.1% | 316 |
|
|
2021
Q3 | $3.2M | Buy |
63,925
+29,401
| +85% | +$1.47M | 0.25% | 163 |
|
|
2021
Q2 | $2.18M | Buy |
34,524
+24,730
| +253% | +$1.56M | 0.19% | 187 |
|
|
2021
Q1 | $910K | Sell |
9,794
-9,365
| -49% | -$870K | 0.08% | 362 |
|
|
2020
Q4 | $1.72M | Buy |
19,159
+9,049
| +90% | +$811K | 0.13% | 248 |
|
|
2020
Q3 | $1.05M | Buy |
+10,110
| New | +$1.05M | 0.07% | 360 |
|